# SLK

## Overview
The SLK gene encodes the STE20-like kinase, a serine/threonine protein kinase that plays a crucial role in various cellular processes, including cell cycle regulation, cytoskeletal dynamics, and cell migration. As a member of the kinase family, SLK is characterized by its N-terminal catalytic domain and C-terminal regulatory domain, which facilitate its enzymatic activity and regulatory functions (Woychyshyn2020Genetic; Cybulsky2017Regulation). The protein is involved in the phosphorylation of substrates such as ezrin, influencing cytoskeletal organization and cell motility (Cybulsky2017Regulation). SLK's activity is modulated through phosphorylation and dimerization, which are essential for its role in processes like mitotic entry, focal adhesion turnover, and apoptosis (Wagner2008FAKsrcFamily; Cybulsky2017Regulation). Alterations in SLK expression and function have been linked to various pathological conditions, including muscular dystrophy, cancer, and kidney disease, underscoring its significance in maintaining cellular and tissue homeostasis (Yang2022Extensive; Woychyshyn2020Genetic; Pryce2017Deletion).

## Structure
The SLK (STE20-like kinase) protein is a serine/threonine kinase characterized by a distinct molecular structure that includes a N-terminal catalytic domain and a C-terminal regulatory domain. The catalytic domain is essential for its enzymatic activity, facilitating phosphorylation of substrates such as ezrin, which is crucial for cytoskeletal dynamics (Woychyshyn2020Genetic; Cybulsky2017Regulation). The C-terminal domain contains coiled-coil regions that are important for dimerization, a process that enhances SLK's autophosphorylation and activation (Cybulsky2017Regulation).

SLK's secondary structure includes alpha helices and beta sheets typical of kinases, contributing to its stability and function (Woychyshyn2020Genetic). The protein undergoes post-translational modifications, notably phosphorylation at key sites such as T183 and S189, which are critical for its activation and function (Woychyshyn2020Genetic; Cybulsky2017Regulation).

SLK may exist in different splice variant isoforms, which can influence its function and localization within the cell (Woychyshyn2020Genetic). These structural features and modifications are integral to SLK's role in various cellular processes, including cell cycle progression and cytoskeletal remodeling.

## Function
The Ste20-like kinase (SLK) is a serine/threonine protein kinase involved in several critical cellular processes, including cell cycle progression, cytoskeletal dynamics, and cell migration. SLK plays a pivotal role in regulating the G2/M transition during the cell cycle by activating polo-like kinase 1 (Plk1), which is essential for mitotic entry and spindle formation (cunha2019vitro; Ellinger‐Ziegelbauer2000Ste20‐like). SLK's activity is modulated by phosphorylation, and it is known to co-localize with the mitotic spindle, interacting with α-tubulin, which is crucial for chromosome alignment and segregation (cunha2019vitro).

In terms of cytoskeletal dynamics, SLK is involved in focal adhesion turnover and cell migration. It is activated downstream of the FAK/c-src complex and localizes to the leading edge of migrating cells, where it interacts with proteins such as paxillin and Rac1 (Wagner2008FAKsrcFamily). SLK's role in actin stress fiber disassembly and focal adhesion dynamics is essential for efficient cell motility, which is crucial for processes like tissue repair and immune responses (Wagner2008FAKsrcFamily).

SLK is also implicated in apoptosis and cellular stress responses, contributing to tissue homeostasis and development (Cybulsky2017Regulation). Its activity is regulated through mechanisms such as phosphorylation and protein-protein interactions, which stabilize the kinase in a catalytically competent conformation (Cybulsky2017Regulation).

## Clinical Significance
Alterations in the SLK (STE20-like kinase) gene have been implicated in several diseases and conditions. In skeletal muscle, the deletion of SLK leads to progressive myopathy and muscle weakness, characterized by delayed muscle regeneration and mislocalization of focal adhesion proteins, which are crucial for myofiber integrity (Pryce2017Deletion). In the context of muscular dystrophy, particularly in the mdx mouse model for Duchenne Muscular Dystrophy, SLK expression is elevated in regenerating fibers, suggesting its role in muscle repair processes (Pryce2021Musclespecific).

In cancer, SLK splicing is extensively altered, with a shift towards the SLK-L isoform in various cancer types, promoting cancer cell proliferation and migration. This dysregulation is linked to cancer progression and metastasis (Yang2022Extensive). In HER2-positive breast cancers, loss of SLK induces a basal/stem-like phenotype, characterized by increased Sox10 expression, which is associated with enhanced tumor growth and a poor prognosis (AlZahrani2020Loss).

In kidney disease, specifically adriamycin nephrosis, SLK deletion in podocytes exacerbates glomerular injury, leading to albuminuria and podocyte damage, highlighting its protective role in maintaining podocyte integrity (Woychyshyn2020Genetic).

## Interactions
SLK (STE20-like kinase) is involved in various protein interactions that are crucial for its function in cellular processes. It interacts with several cytoskeletal proteins, including ezrin, RhoA, paxillin, and the p150 Glued dynactin subunit, which influence cell motility and adhesion (Cybulsky2017Regulation). SLK phosphorylates ezrin, a protein that links F-actin to podocalyxin in podocytes, and this phosphorylation is essential for maintaining podocyte structure (Woychyshyn2020Genetic). The interaction between phosphorylated ezrin and podocalyxin is crucial for the integrity of the podocyte apical membrane (Woychyshyn2020Genetic).

SLK's activity is regulated through dimerization and phosphorylation, with its coiled-coil domains facilitating interactions with other proteins (Cybulsky2017Regulation). Dimerization enhances SLK's autophosphorylation, which is crucial for its activation and ability to phosphorylate substrates like ezrin (Cybulsky2017Regulation). SLK also interacts with the ERM (ezrin/radixin/moesin) proteins, which are important for cell migration and polarity (Serafim2021Discovery).

SLK's interactions extend to its role in fibroblast migration and podocyte injury response, indicating its involvement in cell motility and glomerulonephritis (Cybulsky2017Regulation). These interactions highlight SLK's role as a regulator of cytoskeletal structure and function.


## References


[1. (AlZahrani2020Loss) Khalid N. Al-Zahrani, John Abou-Hamad, David P. Cook, Benjamin R. Pryce, Jonathan J. Hodgins, Cédrik Labrèche, Pascale Robineau-Charette, Christiano T. de Souza, John C. Bell, Rebecca C. Auer, Michele Ardolino, Barbara C. Vanderhyden, and Luc A. Sabourin. Loss of the ste20-like kinase induces a basal/stem-like phenotype in her2-positive breast cancers. Oncogene, 39(23):4592–4602, May 2020. URL: http://dx.doi.org/10.1038/s41388-020-1315-3, doi:10.1038/s41388-020-1315-3. This article has 9 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41388-020-1315-3)

[2. (Serafim2021Discovery) Ricardo A. M. Serafim, Fiona J. Sorrell, Benedict-Tilman Berger, Ross J. Collins, Stanley N. S. Vasconcelos, Katlin B. Massirer, Stefan Knapp, James Bennett, Oleg Fedorov, Hitesh Patel, William J. Zuercher, and Jonathan M. Elkins. Discovery of a potent dual slk/stk10 inhibitor based on a maleimide scaffold. Journal of Medicinal Chemistry, 64(18):13259–13278, August 2021. URL: http://dx.doi.org/10.1021/acs.jmedchem.0c01579, doi:10.1021/acs.jmedchem.0c01579. This article has 9 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1021/acs.jmedchem.0c01579)

[3. (Pryce2017Deletion) Benjamin R. Pryce, Khalid N. Al-Zahrani, Sébastien Dufresne, Natalya Belkina, Cédrik Labrèche, Genaro Patino-Lopez, Jérôme Frenette, Stephen Shaw, and Luc A. Sabourin. Deletion of the ste20-like kinase slk in skeletal muscle results in a progressive myopathy and muscle weakness. Skeletal Muscle, February 2017. URL: http://dx.doi.org/10.1186/s13395-016-0119-1, doi:10.1186/s13395-016-0119-1. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13395-016-0119-1)

[4. (Cybulsky2017Regulation) Andrey V. Cybulsky, Julie Guillemette, Joan Papillon, and Nihad T. Abouelazm. Regulation of ste20-like kinase, slk, activity: dimerization and activation segment phosphorylation. PLOS ONE, 12(5):e0177226, May 2017. URL: http://dx.doi.org/10.1371/journal.pone.0177226, doi:10.1371/journal.pone.0177226. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0177226)

5. (Yang2022Extensive) Extensive Dysregulation of SLK Splicing in Cancers Impacts Metastasis. This article has 0 citations.

[6. (Pryce2021Musclespecific) Benjamin R. Pryce, Cédrik Labrèche, Dounia Hamoudi, John Abou-Hamad, Khalid N. Al-Zahrani, Jonathan J. Hodgins, Antoine Boulanger-Piette, Sabrina Bossé, Cindy Balog-Alvarez, Jérôme Frénette, Michele Ardolino, Joe N. Kornegay, and Luc A. Sabourin. Muscle-specific deletion of slk/stk2 enhances p38 activity and myogenesis in mdx mice. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1868(2):118917, February 2021. URL: http://dx.doi.org/10.1016/j.bbamcr.2020.118917, doi:10.1016/j.bbamcr.2020.118917. This article has 5 citations.](https://doi.org/10.1016/j.bbamcr.2020.118917)

7. (cunha2019vitro) Clinton Royce Cunha. In vitro Characterization of SLK-deficient Mouse Embryonic Fibroblasts (MEFs). PhD thesis, Université d'Ottawa/University of Ottawa, 2019. This article has 0 citations.

[8. (Wagner2008FAKsrcFamily) Simona Wagner, Chris J. Storbeck, Kristin Roovers, Ziad Y. Chaar, Piotr Kolodziej, Marlene McKay, and Luc A. Sabourin. Fak/src-family dependent activation of the ste20-like kinase slk is required for microtubule-dependent focal adhesion turnover and cell migration. PLoS ONE, 3(4):e1868, April 2008. URL: http://dx.doi.org/10.1371/journal.pone.0001868, doi:10.1371/journal.pone.0001868. This article has 48 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0001868)

[9. (Woychyshyn2020Genetic) Boyan Woychyshyn, Joan Papillon, Julie Guillemette, José R. Navarro-Betancourt, and Andrey V. Cybulsky. Genetic ablation of slk exacerbates glomerular injury in adriamycin nephrosis in mice. American Journal of Physiology-Renal Physiology, 318(6):F1377–F1390, June 2020. URL: http://dx.doi.org/10.1152/ajprenal.00028.2020, doi:10.1152/ajprenal.00028.2020. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1152/ajprenal.00028.2020)

[10. (Ellinger‐Ziegelbauer2000Ste20‐like) Heidrun Ellinger‐Ziegelbauer, Hajime Karasuyama, Eitaro Yamada, Kazutake Tsujikawa, Kazuo Todokoro, and Eisuke Nishida. Ste20‐like kinase (slk), a regulatory kinase for polo‐like kinase (plk) during the g2/m transition in somatic cells. Genes to Cells, 5(6):491–498, June 2000. URL: http://dx.doi.org/10.1046/j.1365-2443.2000.00337.x, doi:10.1046/j.1365-2443.2000.00337.x. This article has 71 citations and is from a peer-reviewed journal.](https://doi.org/10.1046/j.1365-2443.2000.00337.x)